Therapeutic Use:

Indications for ANDROXY:

Palliation of advancing inoperable metastatic (skeletal) mammary cancer in women who are 1–5 years postmenopausal. In premenopausal women with breast cancer who have benefited from oophorectomy and are considered to have a hormone-responsive tumor.

Adult:

Individualize. 10–40mg/day in divided doses. Continue therapy for 3 months or more for objective response.